Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$83,502
+$8,245 QoQ
Shares Held
187
+12.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIFLEX GROUP, INC. holds $451,015 across 19 Biotechnology names. VRTX ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
161 | $124,395 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
549 | $103,788 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
187 | $83,502 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
387 | $65,410 | |
| 5 | RPRX |
Royalty Pharma plc
|
340 | $16,309 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
200 | $14,852 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
225 | $10,703 | |
| 8 | MRNA |
Moderna, Inc.
|
163 | $8,280 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,502 | 187 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,257 | 166 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $75,194 | 192 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,040 | 54 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $13,574 | 28 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,027 | 10 | Shares | Sole | 2025-02-24 | |
| No filing history on record for this holder in this stock. | ||||||